NASDAQ
Eagle Pharmaceuticals, Inc. (EGRX) has a free cash flow growth of 99.61% as of Friday, May 29, 2026. This represents a 5.06% decrease compared to its 12-month average of 104.92%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.